Calendar

Here is a look of a few of the biggest clinical trial and FDA updates to watch for in July 2020.
June is nearing its end and the stock market’s recovery along with the overall economic reports have been nearly unimaginable. Employers, investors, day traders, economists and those who are...
Now that June is underway, the recent recovery in unemployment and the continued surge in the stock market have managed to surprise just about everyone. These are also hard to fathom in the wake of...
Now that May’s trading days are over, it’s time to think about June, the summer, and the second half of 2020. The recession is already seeing what economists hope are the worst readings, and the...
Here, 24/7 Wall St. presents a calendar of a few of the biggest clinical trial and FDA updates to watch for in early 2020.
Here, 24/7 Wall St. has included a calendar of a few of the biggest clinical trial and FDA updates to watch for going into 2020.
Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of December.
With China and OPEC both getting partial resolutions, here is what investors, economists and analysts are all on the hunt for the rest of 2019. That is stocks to buy, some that could even double, and...
Abstracts have been released for the companies presenting at the American Association for Cancer Research annual meeting, and Wedbush has some ideas for what the big movers could be.
It's the weekend, but 24/7 Wall St. wanted to show our readers, who may not be on our email list, what they may see each day and on the weekend.
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.
The investing community is preparing for waves of fourth-quarter corporate earnings reports. Some companies likely will post stellar earnings, but where things are looking rather shaky is what to...
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the first quarter of 2019.
24/7 Wall St. takes a look at what is coming up in the FDA calendar regarding biotech and pharmaceutical companies expecting updates to their drug pipeline or other major events for the rest of 2018.
Here 24/7 Wall St. takes a look at a recent report by Canaccord Genuity regarding to biotech and pharmaceutical companies expecting updates to their drug pipeline or other major events for the rest...